Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 224

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Role of the Fatty Acid Binding Protein mal1 in Obesity and Insulin Resistance

Open access
Maeda, Kazuhisa, Uysal, K. Teoman, Makowski, Liza, Görgün, Cem Z., Atsumi, Genichi, Parker, Rex A., Brüning, Jens, Hertzel, Ann Vogel, Bernlohr, David A., Hotamisligil, Gökhan S.·2003·Diabetes

Abstract

The metabolic syndrome is a cluster of metabolic and inflammatory abnormalities including obesity, insulin resistance, type 2 diabetes, hypertension, dyslipidemia, and atherosclerosis. The fatty acid binding proteins aP2 (fatty acid binding protein [FABP]-4) and mal1 (FABP5) are closely related and both are expressed in adipocytes. Previous studies in aP2-deficient mice have indicated a significant role for aP2 in obesity-related insulin resistance, type 2 diabetes, and atherosclerosis. However, the biological functions of mal1 are not known. Here, we report the generation of mice with targeted null mutations in the mal1 gene as well as transgenic mice overexpressing mal1 from the aP2 promoter/enhancer to address the role of this FABP in metabolic regulation in the presence or absence of obesity. To address the role of the second adipocyte FABP in metabolic regulation in the presence and deficiency of obesity, absence of mal1 resulted in increased systemic insulin sensitivity in two models of obesity and insulin resistance. Adipocytes isolated from mal1-deficient mice also exhibited enhanced insulin-stimulated glucose transport capacity. In contrast, mice expressing high levels of mal1 in adipose tissue display reduced systemic insulin sensitivity. Hence, our results demonstrate that mal1 modulates adipose tissue function and contributes to systemic glucose metabolism and constitutes a potential therapeutic target in insulin resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diabetes.52.2.300

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 224

Metadata

Authors
Maeda, K., Uysal, K. T., Makowski, L., Görgün, C. Z., Atsumi, G., Parker, R. A., Brüning, J., Hertzel, A. V., Bernlohr, D. A., & Hotamisligil, G. S.
Venue
Diabetes
Published
2003-02-01
Volume
52
Issue
2
Pages
300-307
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2129457508
Cited by
224
References
3
FWCI
6.05
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of the Fatty Acid Binding Protein mal1 in Obesity and Insulin Resistance. https://app.cochat.ai/papers/10.2337/diabetes.52.2.300
The paper
Maeda, K., Uysal, K. T., Makowski, L., Görgün, C. Z., Atsumi, G., Parker, R. A., Brüning, J., Hertzel, A. V., Bernlohr, D. A., & Hotamisligil, G. S. (2003). Role of the Fatty Acid Binding Protein mal1 in Obesity and Insulin Resistance. Diabetes. https://doi.org/10.2337/diabetes.52.2.300

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.